Porvair Sciences has launched Chromatrap® gDNA Removal Columns that quickly remove unwanted genomic DNA from RNA samples.

ERS Genomics Limited and genOway have announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

10x Genomics has announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the whole transcriptome across their entire tissue, enabling true unbiased discovery in FFPE samples for the first time.

Izon Science Ltd, the manufacturer of nano-biological separation and characterization tools, announced today the release of two new kits: the qEV Concentration Kit for the isolation and concentration of extracellular vesicles (EVs), and the qEV RNA Extraction Kit, which enables the extraction of RNA from EVs.

Foresight Diagnostics has announced the close of its $12.5M Series A financing to commercialize the minimal residual disease (MRD) detection assay.

ERS Genomics Limited has announced that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent. In addition, the JPO has allowed a third CVC patent which covers a chimeric version of the Cas9 protein.

Lonza has launched the next generation of its Nucleofector® Platform.

AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.

Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.

Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.